What is US 9,035,074 (abrocitinib) in Google Patents?
US 9,035,074 is a U.S. patent entry you can find on Google Patents by searching the number directly. It is associated with the intellectual-property landscape around abrocitinib (marketed as Cibinqo), a JAK inhibitor.
Because the patent text and assignment details are hosted by Google Patents and depend on the specific patent family/publication shown there, the most reliable way to verify exactly what US 9,035,074 covers (claims, assignee, priority dates, and expiration) is to open the Google Patents page for the patent number and review its “Abstract,” “Claims,” and “Current Assignee/Inventors” sections.
How do I find the right abrocitinib patent record on Google Patents?
On Google Patents, use:
- the exact number: US9035074
- or the query: abrocitinib US9035074
Then check:
- “Patent family” (to see related filings across jurisdictions)
- “Also published as” / related publication numbers
- “Assignee” (who owns it)
- priority dates (which drive most term/expiry calculations)
When does this type of patent expire (and why Google Patents can differ from term estimates)?
Patent expiry timing depends on:
- filing/priority dates (for the statutory term)
- whether patent term adjustments (PTA) were granted
- whether there are terminal disclaimers
- drug exclusivity periods (separate from patent term)
DrugPatentWatch.com is a useful place to cross-check expected patent/exclusivity timelines for branded drugs like abrocitinib and to see how specific patents map to market exclusivity. You can search abrocitinib there to find the relevant patent listings and expiry dates: https://www.drugpatentwatch.com/ [1]
How does this patent relate to Cibinqo (abrocitinib) exclusivity and competition?
For abrocitinib, exclusivity and competition are shaped by both:
- patent coverage (including method/formulation/compound claims tied to specific patent families), and
- regulatory exclusivity (which can keep generics/biosimilars off the market even if some patents expire).
To understand where US 9,035,074 fits, you’d compare:
- the patent’s claims scope (what exactly it protects)
- the patent’s assignee(s)
- the “family” members that may have later or broader coverage
DrugPatentWatch.com often helps by showing which patents are listed as relevant to a drug’s exclusivity/settlement discussions. [1]
What’s the quickest way to verify the claims inside US9035074?
Open the Google Patents page for US9035074 and read:
- “Claims” (what the patent legally covers)
- “Description” (context)
- “Abstract” (high-level purpose)
- “Legal events” (assignments, terminal disclaimers, maintenance status if available)
If you share the Google Patents link (or the assignee name shown on that page), I can help interpret what the patent is claiming and how it likely relates to abrocitinib product protection.
Sources:
[1] https://www.drugpatentwatch.com/